Showing results (61-70 of 94) with videos related to
Sort By:
Pageof 10
Journal of Neuropathology and Experimental Neurology|January 24, 2018
Discrepancy Between Low Levels of mTOR Activity and High Levels of P-S6 in Primary Central Nervous System Lymphoma May Be Explained by PAS Domain-Containing Serine/Threonine-Protein Kinase-Mediated PhosphorylationDóra Marosvári, Noémi Nagy, Csilla Kriston, et al.Journal of Translational Autoimmunity|June 15, 2026
Upregulated GLUT1 expression correlates with type I interferon activity and disease severity in cutaneous lupus erythematosusLaura Anna Bokor, Botond L Szabolcs, Zsófia Király, et al.Pathology Oncology Research : POR|June 2, 2022
Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition via Modulation of Self-DNA-Triggered TLR9 Signaling and the Autophagy ResponseFerenc Sipos, Bettina Bohusné Barta, Ágnes Simon, et al.Frontiers in Oncology|February 21, 2022
SPOCK1 Promotes the Development of Hepatocellular CarcinomaLóránd Váncza, Katalin Karászi, Bálint Péterfia, et al.Frontiers in Oncology|May 8, 2023
Corrigendum: SPOCK1 promotes the development of hepatocellular carcinomaLóránd Váncza, Katalin Karászi, Bálint Péterfia, et al.International Journal of Molecular Sciences|July 9, 2022
Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic TargetingTitanilla Dankó, Gábor Petővári, Regina Raffay, et al.Journal of Experimental & Clinical Cancer Research : CR|June 6, 2017
Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cellsZoltán Hujber, Gábor Petővári, Norbert Szoboszlai, et al.Plos One|April 11, 2013
Mammalian target of rapamycin (mTOR) activity dependent phospho-protein expression in childhood acute lymphoblastic leukemia (ALL)Karolina Nemes, Anna Sebestyén, Agnes Márk, et al.International Journal of Molecular Sciences|September 23, 2022
Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic CharacteristicsIldikó Krencz, Enikő Vetlényi, Titanilla Dankó, et al.International Journal of Molecular Sciences|August 7, 2021
Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer CellsTitanilla Dankó, Gábor Petővári, Dániel Sztankovics, et al.Pageof 10